Sort
8,912 grants matching “sars cov 2”
Coaching, Collaboration, Cleaning, & Communication: 4C Intervention to Reduce SARS-CoV-2 Transmission
$465,657Raymond L Yung · University Of Michigan At Ann Arbor · P30 · FY2020 · AG
Identifying the Long-Term Neurological Effects of COVID-19 Using 7 Tesla Multi-Modal MRI
$465,438Priti Balchandani · Icahn School Of Medicine At Mount Sinai · R21 · FY2021 · NS
Collaborative Research: Nucleobase-Modified PNA for Sequence Selective Triple-Helical Recognition of Non-Coding RNA
$465,000Eriks Rozners · Suny At Binghamton · · FY2024 · MPS
CIVIC SARS-CoV-2 Research Activities
$464,973Tony Moody · Duke University · N01 · FY2022 · AI
The role of the mRNA-based or Newcastle disease virus (NDV)-based vaccine platform in mucosal B cell priming and recirculation
$464,750Weina Sun · Icahn School Of Medicine At Mount Sinai · R21 · FY2025 · AI
Receptor recognition and cell entry of coronaviruses
$464,440Fang Li · University Of Minnesota · R01 · FY2016 · AI
Administrative Core
$464,363John P. Kirwan · Lsu Pennington Biomedical Research Ctr · U54 · FY2023 · GM
Mechanism and Function of ISG15
$464,326Jon Huibregtse · University Of Texas At Austin · R01 · FY2022 · AI
Mechanism and Function of ISG15
$464,326Jon Huibregtse · University Of Texas At Austin · R01 · FY2021 · AI
Mechanism and Function of ISG15
$464,326Jon Huibregtse · University Of Texas At Austin · R01 · FY2024 · AI
Mechanism and Function of ISG15
$464,326Jon Huibregtse · University Of Texas At Austin · R01 · FY2023 · AI
Mechanism and Function of ISG15
$464,326Jon Huibregtse · University Of Texas At Austin · R01 · FY2025 · AI
The UNC Chapel Hill Superfund Research Program (UNC-SRP)
$464,251Rebecca Fry · Univ Of North Carolina Chapel Hill · P42 · FY2020 · ES
Novel Methods for Clinical Trials in Dementia and Cognitive Decline
$463,746Donald R Royall · University Of Texas Hlth Science Center · R01 · FY2023 · AG
Exploring the Coronavirus Exoribonuclease as an Antiviral Target
$463,700Sandra K Weller · University Of Connecticut Sch Of Med/Dnt · R21 · FY2021 · AI
Nitric oxide-mediated changes in glymphatic and CSF systems in aging and Alzheimer's disease
$463,521Grigori N Enikolopov · State University New York Stony Brook · RF1 · FY2020 · AG
Multiplex point-of-care test for diagnosis, prognosis and serology of COVID19
$463,414Ashutosh Chilkoti · Duke University · R01 · FY2023 · AI
Mechanisms of Cognitive Control Impairment in ME/CFS and PASC-ME/CFS
$463,290H Hamdi Eryilmaz · Massachusetts General Hospital · R01 · FY2024 · NS
Rotavirus Genome Replication and Virion Assembly
$463,005Sarah Marie McDonald Esstman · Wake Forest University · R01 · FY2022 · AI
Development of NLRP3 inflammasome inhibitors towards Alzheimer's disease
$462,952Shijun Zhang · Virginia Commonwealth University · R01 · FY2020 · AG
Factors Responsible for the Development of Post-Acute Sequelae of Acute COVID Infection (PASC) In Hawaii
$462,752Gehan Devendra · University Of Hawaii At Manoa · U54 · FY2022 · MD
Factors Responsible for the Development of Post-Acute Sequelae of Acute COVID Infection (PASC) In Hawaii
$462,752Gehan Devendra · University Of Hawaii At Manoa · U54 · FY2023 · MD
The Molecular and Cellular Basis of Infectious Diseases (MCBID) Program
$462,229Arturo Casadevall · Johns Hopkins University · T32 · FY2025 · AI
COVID-19: Assay Development, HTS and Drug Repurposing to identify potential therapeutics against SARS-CoV-2
$462,178Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Project 4
$462,148Ignacio E. Sanz · Emory University · P01 · FY2025 · AI